Case Study: Publicly-Traded Biotech Company achieves greater efficiency and cost savings with Patlytics

Publicly-traded biotech company increases efficiency and realizes cost savings with Patlytics

Publicly-Traded Biotech Company, a global, publicly traded biotechnology firm focused on rare diseases and a large IP portfolio, faced heavy patenting demands — roughly 15–30 from‑scratch applications a year across more than 30 preclinical programs — and time-consuming prior art searches. Seeking AI that actually improves productivity, the company evaluated Patlytics’ AI‑powered patent drafting and search platform to speed drafting and enhance search results.

Patlytics delivered flexible, AI-driven patent drafting and prior art tools that produced high‑quality first drafts and claim sets, complementing the company’s existing search solutions. The company reported saving about 10–15 hours per application and an estimated $5,000–$7,500 in external costs per patent by avoiding billable hours, while uncovering prior art insights other tools missed and enabling the IP team to focus on higher‑value strategy.